Home > Insider Trading > Filing (0001209191-13-026179)

Filing Details

Accession Number:: 0001209191-13-026179
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-14 16:30:40
Reporting Period:: 2013-05-10

Filing Date:: 2013-05-14
Accepted Time:: 2013-05-14 16:30:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1500430	M Lance Culbreth	100 North Point Center East Suite 200 Alpharetta GA 30022	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-10	8,000	$9.29	32,106	No	4	M	Direct
Common Stock	Disposition	2013-05-10	16,000	$18.54	16,106	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2013-05-10	8,000	$0.00	8,000	$9.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-09-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership
Restricted Stock	2,931	Direct
Restricted Stock	1,466	Direct
Restricted Stock	1,466	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$9.68	2016-07-05	3,200	3,200	Direct
Common Stock	Stock Options (Right to Buy)	$9.29	2017-09-10	8,000	8,000	Direct
Common Stock	Stock Options (Right to Buy)	$15.95	2018-03-25	9,126	9,126	Direct
Common Stock	Stock-Settled Stock Appreciation Rights	$14.74	2016-01-05	12,133	12,133	Direct
Common Stock	Stock-Settled Stock Appreciation Rights	$18.14	2017-11-23	3,777	3,777	Direct
Common Stock	Stock-Settled Stock Appreciation Rights	$18.14	2017-11-23	48,000	48,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-07-05	3,200	3,200	Direct
2017-09-10	8,000	8,000	Direct
2018-03-25	9,126	9,126	Direct
2016-01-05	12,133	12,133	Direct
2017-11-23	3,777	3,777	Direct
2017-11-23	48,000	48,000	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
The reporting person was granted these stock options on September 17, 2007 and are fully vested.
The reporting person was granted these stock options on July 5, 2006 and are fully vested.
The reporting person was granted these stock options on September 10, 2007 and are fully vested.
The reporting person was granted these stock options on March 25, 2008 and are fully vested.
The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009 and are fully vested.
The reporting person was granted these SSARs on November 23, 2010 and are fully vested.
The reporting person was granted these SSARs on November 23, 2010. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2010 such that 100% of the SSARs will be fully vested on October 1, 2015.